About MgShell
MgShell is a company based in Milano (Italy) founded in 2019 by Matteo Giuseppe Cereda, Federica Boschetti, Francesco De Gaetano, and Marco Ferroni.. MgShell has raised $1.83 million across 2 funding rounds from investors including Capital Cell, Bios Line and Club degli Investitori. MgShell offers products and services including Magnesium-based Drug Delivery Platform. MgShell operates in a competitive market with competitors including Eyenovia, Kedalion Thera, PolyActiva, iVeena Delivery Systems and Re-Vana Therapeutics, among others.
- Headquarter Milano, Italy
- Founders Matteo Giuseppe Cereda, Federica Boschetti, Francesco De Gaetano, Marco Ferroni
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mgshell Srl
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.83 M (USD)
in 2 rounds
-
Latest Funding Round
$1.3 M (USD), Series A
Apr 30, 2025
-
Investors
Capital Cell
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MgShell
MgShell offers a comprehensive portfolio of products and services, including Magnesium-based Drug Delivery Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for delivering drugs to treat retinal diseases using magnesium innovations.
Funding Insights of MgShell
MgShell has successfully raised a total of $1.83M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $1.3 million completed in April 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $1.3M
-
First Round
First Round
(08 Feb 2023)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2025 | Amount | Series A - MgShell | Valuation | Capital Cell | |
| Feb, 2023 | Amount | Seed - MgShell | Valuation | Bios Line Holding , Club degli Investitori |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in MgShell
MgShell has secured backing from 6 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Capital Cell, Bios Line and Club degli Investitori. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A network of business angels investing in innovative companies is operated.
|
Founded Year | Domain | Location | |
|
Investments in early-stage biotech and life sciences are enabled.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by MgShell
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - MgShell
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mgshell Comparisons
Competitors of MgShell
MgShell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eyenovia, Kedalion Thera, PolyActiva, iVeena Delivery Systems and Re-Vana Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Microdose therapies for myopia treatment are developed with Optejet dispenser.
|
|
| domain | founded_year | HQ Location |
Provider of drug delivery system for eye diseases
|
|
| domain | founded_year | HQ Location |
A platform for slow-release, site-specific drug delivery is developed.
|
|
| domain | founded_year | HQ Location |
Ocular drug products for drop-free cataract surgery are developed.
|
|
| domain | founded_year | HQ Location |
Drug delivery platform for ophthalmic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Drug & a cell targeting system for posterior segment eye diseases
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mgshell
Frequently Asked Questions about MgShell
When was MgShell founded?
MgShell was founded in 2019 and raised its 1st funding round 4 years after it was founded.
Where is MgShell located?
MgShell is headquartered in Milano, Italy.
Who is the current CEO of MgShell?
Marco Ferroni is the current CEO of MgShell. They have also founded this company.
Is MgShell a funded company?
MgShell is a funded company, having raised a total of $1.83M across 2 funding rounds to date. The company's 1st funding round was a Seed of $535.94K, raised on Feb 08, 2023.
What does MgShell do?
MgShell developer of an intraocular device for drug delivery, focusing on life sciences, ophthalmology, developing medical devices, therapy, and ocular drug delivery. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Who are the top competitors of MgShell?
MgShell's top competitors include Eyenovia, PolyActiva and iVeena Delivery Systems.
What products or services does MgShell offer?
MgShell offers Magnesium-based Drug Delivery Platform.
Who are MgShell's investors?
MgShell has 6 investors. Key investors include Capital Cell, Bios Line, Club degli Investitori, Italian Angels for Biotech, and Lucio Rovati.